Biotech Values

[DewDiligence]

…it violates one of my standard rules of biotech investing—don't invest in companies that change their name.

Should an exception be made for companies that change only the form of their name, keeping the same root? E.g. Incyte Pharmaceuticals became Incyte Genomics, which became Incyte Corporation (the current name).